x

Passage BIO, Inc. (Nasdaq:PASG)

Health Care/Life Sciences • Biotechnology
CIK 1787297
Company

Passage Bio, Inc. operates as a genetic medicines company. It focuses on developing transformative therapies for rare, monogenic central nervous system disorders with limited or no approved treatment options. The company assembles a portfolio of genetic medicine products, which includes PBGM01 for the treatment of GM1, PBFT02 for the treatment of FTD and PBKR03 for the treatment of Krabbe disease. Passage Bio was founded by Stephen P. Squinto, Tadataka Yamada, David A. Socks, Aditya Kohli, and James M. Wilson in July 2017 and is headquartered in Philadelphia, PA.

Address
One Commerce Square
2005 Market Street
39th floor
Philadelphia, Pennsylvania 19103
Employees
85
Stock Info
Close
$1.6800
Day Range
1.4500 - 1.6900
52 Week Range
0.5751 - 1.7400
Average volume
642.56K
Short Interest
251.25K (02/15/24)
% of Float Shorted
0.69%
Market Cap
$93.74M
Revenue
N/A
Net Income
-$136.13M
2020 Sales Growth
N/A
Rev. per Employee
N/A
P/E Ratio
N/A
EPS
-$1.8647
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
President, Chief Executive Officer & Director
William Chou MD, MBA
Director
Dolan Sondhi PhD
Chairman
Maxine Gowen PhD, MBA
Independent Director
Athena M Countouriotis MD
Independent Director
Derrell D Porter MD, MBA
Independent Non-Executive Director
Sandipkumar S Kapadia MBA, CPA
Independent Director
Michael E Kamarck PhD
SEC filings
DateFormEvent
11 Dec, 2024 4
6 Dec, 2024 4
4 Dec, 2024 144
4 Dec, 2024 144
27 Nov, 2024 4
14 Nov, 2024 SCHEDULE 1
14 Nov, 2024 SCHEDULE 1
14 Nov, 2024 SC 13G
13 Nov, 2024 10-Q
13 Nov, 2024 8-K
24 Oct, 2024 8-K
2 Oct, 2024 4
2 Oct, 2024 4
2 Oct, 2024 3
23 Sep, 2024 4
18 Sep, 2024 4
16 Sep, 2024 144
16 Sep, 2024 8-K
16 Sep, 2024 144
10 Sep, 2024 8-K
6 Sep, 2024 8-K
9 Aug, 2024 3
9 Aug, 2024 SC 13G/A
9 Aug, 2024 SC 13D/A
8 Aug, 2024 10-Q
8 Aug, 2024 8-K
2 Aug, 2024 8-K
1 Aug, 2024 8-K
16 Jul, 2024 8-K
29 May, 2024 SC 13D/A
23 May, 2024 4
23 May, 2024 4
23 May, 2024 4
23 May, 2024 4
23 May, 2024 4
23 May, 2024 4
22 May, 2024 8-K
14 May, 2024 8-K
14 May, 2024 424B3
14 May, 2024 10-Q
16 Apr, 2024 EFFECT
12 Apr, 2024 CORRESP
12 Apr, 2024 SC 13D/A
9 Apr, 2024 ARS
9 Apr, 2024 DEFA14A
9 Apr, 2024 DEF 14A
29 Mar, 2024 SC 13G
19 Mar, 2024 4
19 Mar, 2024 4
19 Mar, 2024 4
19 Mar, 2024 4
7 Mar, 2024 UPLOAD
4 Mar, 2024 S-8
4 Mar, 2024 10-K
4 Mar, 2024 S-3
4 Mar, 2024 8-K
29 Feb, 2024 8-K
14 Feb, 2024 SC 13G/A
13 Feb, 2024 4
13 Feb, 2024 4
5 Jan, 2024 8-K
3 Jan, 2024 4
3 Jan, 2024 4
3 Jan, 2024 4
29 Dec, 2023 8-K
20 Dec, 2023 8-K
13 Nov, 2023 8-K
13 Nov, 2023 10-Q
9 Nov, 2023 SC 13D/A
1 Sep, 2023 8-K
7 Aug, 2023 8-K
7 Aug, 2023 10-Q
1 Aug, 2023 4
31 Jul, 2023 8-K
31 Jul, 2023 4
31 Jul, 2023 3
28 Jul, 2023 4
28 Jul, 2023 3
20 Jul, 2023 8-K
29 Jun, 2023 SC 13D/A
29 Jun, 2023 4
15 Jun, 2023 SC 13D/A
26 May, 2023 4
26 May, 2023 8-K
26 May, 2023 4
26 May, 2023 4
26 May, 2023 4
26 May, 2023 4
26 May, 2023 4
26 May, 2023 4
11 May, 2023 8-K
11 May, 2023 10-Q
20 Apr, 2023 4
14 Apr, 2023 DEFA14A
14 Apr, 2023 ARS
14 Apr, 2023 DEF 14A
6 Apr, 2023 8-K
5 Apr, 2023 4
5 Apr, 2023 4
5 Apr, 2023 4
5 Apr, 2023 4
5 Apr, 2023 4
3 Apr, 2023 PRE 14A
10 Mar, 2023 8-K
6 Mar, 2023 10-K
6 Mar, 2023 8-K
6 Mar, 2023 S-8
24 Feb, 2023 8-K
14 Feb, 2023 SC 13G/A
14 Feb, 2023 SC 13G/A
9 Jan, 2023 8-K
14 Dec, 2022 8-K
2 Dec, 2022 8-K
2 Dec, 2022 4
18 Nov, 2022 4
14 Nov, 2022 4
14 Nov, 2022 4
14 Nov, 2022 4
14 Nov, 2022 4
10 Nov, 2022 8-K
10 Nov, 2022 10-Q
12 Oct, 2022 3
12 Oct, 2022 4
11 Oct, 2022 8-K CEO Change
29 Sep, 2022 SC 13G
15 Aug, 2022 SC 13D/A
11 Aug, 2022 8-K
4 Aug, 2022 10-Q
4 Aug, 2022 8-K
8 Jul, 2022 SC 13G
6 Jul, 2022 4
6 Jul, 2022 8-K
6 Jul, 2022 3
15 Jun, 2022 4
15 Jun, 2022 4
15 Jun, 2022 4
15 Jun, 2022 4
15 Jun, 2022 4
8 Jun, 2022 8-K
1 Jun, 2022 4
1 Jun, 2022 4
1 Jun, 2022 4
1 Jun, 2022 8-K CEO Change
31 May, 2022 4
31 May, 2022 4
31 May, 2022 4
31 May, 2022 4
31 May, 2022 4
31 May, 2022 4
18 May, 2022 8-K
16 May, 2022 8-K
16 May, 2022 10-Q
5 May, 2022 4/A
5 May, 2022 SC 13D/A
5 May, 2022 4
20 Apr, 2022 4
20 Apr, 2022 4
14 Apr, 2022 EFFECT
14 Apr, 2022 DEF 14A
14 Apr, 2022 DEFA14A
8 Apr, 2022 3
23 Mar, 2022 4
15 Mar, 2022 8-K
11 Mar, 2022 8-K
10 Mar, 2022 8-K
3 Mar, 2022 S-8
3 Mar, 2022 POS AM
3 Mar, 2022 POS AM
3 Mar, 2022 POSASR
3 Mar, 2022 8-K
3 Mar, 2022 10-K
14 Feb, 2022 SC 13G/A
14 Feb, 2022 SC 13G/A
14 Feb, 2022 4
14 Feb, 2022 4
14 Feb, 2022 4
14 Feb, 2022 4
14 Feb, 2022 4
14 Feb, 2022 4
11 Feb, 2022 8-K
9 Feb, 2022 SC 13G/A
4 Feb, 2022 SC 13G
24 Jan, 2022 4
20 Jan, 2022 4
13 Jan, 2022 4
10 Jan, 2022 8-K
17 Dec, 2021 8-K
10 Dec, 2021 4
10 Dec, 2021 SC 13G/A
4 Nov, 2021 10-Q
4 Nov, 2021 8-K
1 Nov, 2021 8-K
25 Oct, 2021 SC 13G
4 Oct, 2021 8-K
25 Aug, 2021 4
25 Aug, 2021 3
5 Aug, 2021 10-Q
5 Aug, 2021 8-K
21 Jul, 2021 4
21 Jul, 2021 3
21 Jul, 2021 8-K CEO Change
19 Jul, 2021 S-8
9 Jun, 2021 3
1 Jun, 2021 4
28 May, 2021 4
28 May, 2021 3
28 May, 2021 4
28 May, 2021 4
28 May, 2021 4
28 May, 2021 4
28 May, 2021 4
28 May, 2021 4
28 May, 2021 8-K
21 May, 2021 4
21 May, 2021 4
19 May, 2021 4
18 May, 2021 8-K
5 May, 2021 10-Q
5 May, 2021 8-K
14 Apr, 2021 DEFA14A
14 Apr, 2021 DEF 14A
29 Mar, 2021 3
29 Mar, 2021 4
22 Mar, 2021 8-K
17 Mar, 2021 4
5 Mar, 2021 S-3ASR
5 Mar, 2021 S-8
3 Mar, 2021 8-K
3 Mar, 2021 10-K
22 Feb, 2021 3
22 Feb, 2021 4
19 Feb, 2021 8-K
18 Feb, 2021 4
18 Feb, 2021 4
18 Feb, 2021 4
18 Feb, 2021 4
18 Feb, 2021 4
18 Feb, 2021 4
17 Feb, 2021 8-K
12 Feb, 2021 SC 13G/A
11 Feb, 2021 SC 13G
9 Feb, 2021 SC 13G
8 Feb, 2021 SC 13G/A
28 Jan, 2021 SC 13D/A
27 Jan, 2021 SC 13D/A
22 Jan, 2021 4
22 Jan, 2021 424B1
21 Jan, 2021 EFFECT
19 Jan, 2021 CORRESP
19 Jan, 2021 S-1
19 Jan, 2021 CORRESP
15 Jan, 2021 4
11 Jan, 2021 8-K
22 Dec, 2020 UPLOAD
18 Dec, 2020 DRS
Last update:2024-03-06 13:25:00.101571
Passage BIO, Inc. by TradingView

Sign Up to Subscribe